<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=319805651697215&amp;ev=PageView&amp;noscript=1">

Cryoport to Report Financial Results for Fiscal Third Quarter of 2015 and Provide Business Update on Thursday, February 5th

January 29, 2015

Lake Forest, CA, January 29, 2015 - Cryoport, Inc. (OTCBB:CYRX) (“Company”), the leading provider of advanced cryogenic logistics solutions for life sciences serving markets including immunotherapies, stem cells, cell lines, clinical research organizations, vaccine manufacturers, and reproductive medicine, today announced it will release its financial results for the fiscal third quarter ended December 31, 2014 on Thursday, February 5th.  

Read More


Tags: Frozen Shipping, shipping solution, Frozen, sales force, Life Sciences, Cold Chain Logistics, Dry Shipper, cold shipping, Clinical Trials Logistics

Cryoport Expands Sales Force To Address Growing Life Sciences Industry Demand

January 26, 2015

Lake Forest, CA, January 26, 2015 - Cryoport, Inc. (OTCBB: CYRX) (“Company”), the leading provider of advanced cryogenic logistics solutions for life sciences serving markets including immunotherapies, stem cells, cell lines, clinical research organizations, vaccine manufacturers, and reproductive medicine, today announced the expansion and restructuring of its national sales force in the United States.

Read More


Tags: Frozen Shipping, shipping solution, Frozen, sales force, Life Sciences, Cold Chain Logistics, Dry Shipper, cold shipping, Clinical Trials Logistics

Cryoport Appoints Mark W. Sawicki as Chief Commercial Officer to Lead Sales and Marketing Team

January 20, 2015

Lake Forest, CA, January 20, 2015 - Cryoport, Inc. (OTCBB: CYRX) ( “Company”), the leading provider of advanced cryogenic logistics solutions for life sciences serving markets including immunotherapies, stem cells, cell lines, clinical research organizations, vaccine manufacturers and reproductive medicine, today announced the appointment of Mark W. Sawicki, Ph.D. as Chief Commercial Officer of Cryoport Systems.

Read More


Tags: Frozen Shipping, shipping solution, Frozen, board, Cold Chain Logistics, Dry Shipper, cold shipping, Clinical Trials Logistics

Cryoport Appoints Richard J. Berman to its Board of Directors

January 12, 2015

Lake Forest, CA, January 12, 2015 - Cryoport, Inc. (OTC BB:CYRX) (“Company”), the leading provider of advanced  cryogenic logistics solutions for life sciences serving markets including immunotherapies, stem cells, cell lines, contract research organizations , vaccine manufacturers, and IVF, today announced the appointment of Richard J. Berman to its Board of Directors. Mr. Berman will also serve as Chairman of the Audit Committee and Compensation Committee.

Read More


Tags: Frozen Shipping, shipping solution, Frozen, board, Richard J. Berman, Cold Chain Logistics, Dry Shipper, cold shipping, Clinical Trials Logistics

Cryoport Increases Revenue by 65% for the First Six Months of Fiscal 2015

November 12, 2014

LAKE FOREST, CA – November 12, 2014 — Cryoport, Inc. (OTCBB: CYRX) today announced financial results for its second quarter and six months ended September 30, 2014.

Read More


Tags: Frozen Shipping, Revenue, fiscal 2015, Cold Chain Logistics, Dry Shipper, cold shipping, Clinical Trials Logistics

Cryoport & UPS Collaborate on Cryogenic Logistics Solutions for the Healthcare Industry

November 3, 2014

Lake Forest, CA, November 3, 2014 - Cryoport, Inc. (OTC BB: CYRX) ("the Company"), the leading provider of advanced cryogenic logistics solutions, announced today that it is collaborating with UPS to enhance its temperature-sensitive shipping offerings to the healthcare industry.

Read More


Tags: Frozen Shipping, UPS, frozen shipping solution, Cold Chain Logistics, Press Releases, Dry Shipper, cold shipping, Clinical Trials Logistics, News

Cryoport Begins Delivering Novel Cryogenically Preserved Knee OA Treatment to Orthopedists

October 14, 2014

Lake Forest, CA (October 14, 2014) - Cryoport, Inc. (OTC:CYRX) announced today the first phase of deploying its “Regenerative Medicine Point-of-Care Repository Solution” for Liventa Bioscience’s introduction of Liventa’s AmnioClear® LCT therapy to orthopedic clinics in the US. More than 70 orthopedic clinics have expressed interest in the therapy. Of these clinics, approximately 20 have entered into a registry/ clinical study with Liventa.  

Read More


Tags: Frozen Shipping, Liventa, Regenerative Medicine Point-of-Care Repository Sol, AmnioClear®, Cold Chain Logistics, Dry Shipper, cold shipping

Cryoport Engages Broekman Group to Enhance Its Logistics and Operational Support in Europe

September 16, 2014

LAKE FOREST, CA – September 16, 2014 — Cryoport, Inc. (OTC BB: CYRX) ("the Company"), the world’s leading provider of advanced cryogenic logistics solutions for the life-sciences industry, announced today that it has engaged Broekman Group, a global logistics company headquartered in Rotterdam, the Netherlands, to provide support to their rapidly expanding European client base. According to the terms of the agreement, Broekman’s European operations will support Cryoport’s leading-edge cryogenic logistics solutions throughout Europe.

Read More


Tags: Frozen Shipping, Europe, Broekman Group, Cold Chain Logistics, Dry Shipper, cold shipping, Clinical Trials Logistics

Cryoport Appoints VP of Strategic Business Development and Accelerates Expansion of Direct Sales Force

September 8, 2014

LAKE FOREST, CA – September 8, 2014 — Cryoport, Inc. (OTC BB: CYRX) ("the Company"), the leading provider of advanced cryogenic logistics solutions for the life sciences industry, announced today the appointment of Curt Kole to the new role of VP, Strategic Business Development. Cryoport’s new business development personnel will support the Company’s rapid development and integration of large-scale corporate clients. In addition to securing new business sectors and major accounts for Cryoport, this new function will be responsible for the management of many key partnerships for the Company.

Read More


Tags: Frozen Shipping, sales, business development, Curt Kole, VP of Strategic Business Development, Cold Chain Logistics, Dry Shipper, cold shipping, Clinical Trials Logistics

Cryoport to Present at the Aegis Healthcare & Technology Conference on September 12, 2014

September 2, 2014

LAKE FOREST, CA – September 2, 2014 — Cryoport, Inc. (OTC BB: CYRX) ("the Company"), the leading provider of advanced cryogenic logistics solutions, announced today that its Chief Financial Officer, Robert Stefanovich, is scheduled to present at the Aegis Healthcare & Technology Conference on Friday, September 12, 2014 at 1:30 pm PT, at The Encore at Wynn Las Vegas.

Read More


Tags: Frozen Shipping, Aegis Healthcare & Technology Conference, Cold Chain Logistics, Dry Shipper, cold shipping, Clinical Trials Logistics